357 related articles for article (PubMed ID: 15205474)
1. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
[TBL] [Abstract][Full Text] [Related]
2. Delineation of the IGF-II C domain elements involved in binding and activation of the IR-A, IR-B and IGF-IR.
Henderson ST; Brierley GV; Surinya KH; Priebe IK; Catcheside DE; Wallace JC; Forbes BE; Cosgrove LJ
Growth Horm IGF Res; 2015 Feb; 25(1):20-7. PubMed ID: 25458127
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of insulin receptor isoforms by insulin-like growth factors is determined by the C domain.
Denley A; Brierley GV; Carroll JM; Lindenberg A; Booker GW; Cosgrove LJ; Wallace JC; Forbes BE; Roberts CT
Endocrinology; 2006 Feb; 147(2):1029-36. PubMed ID: 16239300
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
5. The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review.
Denley A; Wallace JC; Cosgrove LJ; Forbes BE
Horm Metab Res; 2003; 35(11-12):778-85. PubMed ID: 14710358
[TBL] [Abstract][Full Text] [Related]
6. Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation.
Benyoucef S; Surinya KH; Hadaschik D; Siddle K
Biochem J; 2007 May; 403(3):603-13. PubMed ID: 17291192
[TBL] [Abstract][Full Text] [Related]
7. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
8. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer.
Vella V; Pandini G; Sciacca L; Mineo R; Vigneri R; Pezzino V; Belfiore A
J Clin Endocrinol Metab; 2002 Jan; 87(1):245-54. PubMed ID: 11788654
[TBL] [Abstract][Full Text] [Related]
9. Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain.
Hexnerová R; Křížková K; Fábry M; Sieglová I; Kedrová K; Collinsová M; Ullrichová P; Srb P; Williams C; Crump MP; Tošner Z; Jiráček J; Veverka V; Žáková L
J Biol Chem; 2016 Sep; 291(40):21234-21245. PubMed ID: 27510031
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor.
Gauguin L; Klaproth B; Sajid W; Andersen AS; McNeil KA; Forbes BE; De Meyts P
J Biol Chem; 2008 Feb; 283(5):2604-13. PubMed ID: 18048361
[TBL] [Abstract][Full Text] [Related]
11. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.
Sciacca L; Costantino A; Pandini G; Mineo R; Frasca F; Scalia P; Sbraccia P; Goldfine ID; Vigneri R; Belfiore A
Oncogene; 1999 Apr; 18(15):2471-9. PubMed ID: 10229198
[TBL] [Abstract][Full Text] [Related]
12. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
[TBL] [Abstract][Full Text] [Related]
13. Insulin-Insulin-like Growth Factors Hybrids as Molecular Probes of Hormone:Receptor Binding Specificity.
Křížková K; Chrudinová M; Povalová A; Selicharová I; Collinsová M; Vaněk V; Brzozowski AM; Jiráček J; Žáková L
Biochemistry; 2016 May; 55(21):2903-13. PubMed ID: 27171135
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
15. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants.
Schumacher R; Soos MA; Schlessinger J; Brandenburg D; Siddle K; Ullrich A
J Biol Chem; 1993 Jan; 268(2):1087-94. PubMed ID: 7678247
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.
Frasca F; Pandini G; Scalia P; Sciacca L; Mineo R; Costantino A; Goldfine ID; Belfiore A; Vigneri R
Mol Cell Biol; 1999 May; 19(5):3278-88. PubMed ID: 10207053
[TBL] [Abstract][Full Text] [Related]
17. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.
Belfiore A; Frasca F; Pandini G; Sciacca L; Vigneri R
Endocr Rev; 2009 Oct; 30(6):586-623. PubMed ID: 19752219
[TBL] [Abstract][Full Text] [Related]
18. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
19. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
20. Selective response to insulin versus insulin-like growth factor-I and -II and up-regulation of insulin receptor splice variant B in the differentiated mouse mammary epithelium.
Berlato C; Doppler W
Endocrinology; 2009 Jun; 150(6):2924-33. PubMed ID: 19246539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
